No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Thursday, October 9, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Startups

Wageningen-based Scope Biosciences lands fresh capital to advance CRISPR-based molecular diagnostics platform

by TheAdviserMagazine
4 months ago
in Startups
Reading Time: 2 mins read
A A
Wageningen-based Scope Biosciences lands fresh capital to advance CRISPR-based molecular diagnostics platform
Share on FacebookShare on TwitterShare on LInkedIn


Scope Biosciences, a deep tech spin-off from Wageningen University & Research, has secured a follow-on investment from SHIFT Invest and Oost NL to advance its CRISPR-based molecular diagnostics platform.

Founded by CEO Niek Savelkoul and headquartered in Wageningen, the Netherlands, Scope Biosciences has now raised a total of €6M in seed-stage funding, combining strategic and venture capital investments with non-dilutive support from leading European and Dutch innovation programmes.

The funding follows the company’s strong progression and first significant commercial traction. Including this new capital, together with a previously awarded €2.5M EIC Transition Grant and earlier investments, ScopeBio has secured comprehensive funding to scale up and build out its platform for real-world diagnostic challenges.

The round represents continued backing from existing investors SHIFT Invest and Oost NL. Scope Biosciences has developed its scopeDx technology to enable diagnostics closer to the source, addressing challenges in both agricultural and healthcare markets where centralised laboratories are not readily available.

Scope Biosciences: Ultra-precise, field-ready diagnostics without proprietary hardware

At the heart of Scope Biosciences’s mission is its next-generation CRISPR-based molecular diagnostics platform — scopeDx — that delivers ultra-precise, single-nucleotide detection in a portable, field-ready format without proprietary hardware or centralised labs.

The technology enables earlier and more effective detection of crop diseases in agriculture, helping to reduce losses and improve yields, whilst in healthcare, it contributes to faster and broader access to reliable testing, especially in areas where centralised laboratories are not available.

The molecular diagnostics market is experiencing significant growth as demand increases for point-of-care testing solutions that can operate outside traditional laboratory settings.

From Wageningen research to commercial diagnostics platform

CEO and founder Niek Savelkoul built the company as a spin-off from Wageningen University & Research, leveraging deep technical expertise in molecular diagnostics.

SHIFT Invest brings sector-specific experience in agricultural technology investments, whilst Oost NL focuses on regional innovation with global relevance in the East Netherlands ecosystem.

“We’re grateful for the continued backing of SHIFT and Oost NL, and proud to have secured significant public and private support as we bring our technology closer to market,” says Niek Savelkoul, CEO and founder of ScopeBio. “We’re scaling up, building out our platform, and getting ready to meet real-world diagnostic challenges head-on.”

“We are proud to provide our continued support to ScopeBio. Over the past couple of years, we have closely followed ScopeBio’s progress in commercialising their highly accurate, on-site diagnostic platform in agriculture. We are excited to see the team tackling the healthcare market with the same level of determination,” says Sophie van Weede, Associate at SHIFT Invest.

Regional innovation hub driving global diagnostic solutions

ScopeBio is embedded in the vibrant innovation ecosystem of the East Netherlands region, operating from the Wageningen Campus. The company has demonstrated commercial traction in agricultural diagnostics while expanding into healthcare applications.

“ScopeBio’s technology aligns perfectly with our ambition to foster regional innovation with global relevance. We are proud to support this pioneering company as it enters its next growth phase,” says Maureen Haverkamp, Investment Manager at Oost NL.



Source link

Tags: advanceBiosciencesCapitalCRISPRbasedDiagnosticsFreshlandsMolecularplatformScopeWageningenbased
ShareTweetShare
Previous Post

Meet Blaise Metreweli, the first woman chief of UK spy agency MI6

Next Post

Eight dead in heavy overnight missile barrage

Related Posts

edit post
Germany’s industrial AI startup findIQ launches US expansion after €3.4M Seed funding

Germany’s industrial AI startup findIQ launches US expansion after €3.4M Seed funding

by TheAdviserMagazine
October 9, 2025
0

Herford, Germany-based findIQ, a company that specialises in an AI-based knowledge platform, announced its expansion into the US market with...

edit post
Here’s what it’s really like to appear on billionaire VC Tim Draper’s ‘Meet the Drapers’ pitch show

Here’s what it’s really like to appear on billionaire VC Tim Draper’s ‘Meet the Drapers’ pitch show

by TheAdviserMagazine
October 8, 2025
0

There was barely a breeze on the roof of the MCM studios building in Manhattan last week as six entrepreneurs...

edit post
Amsterdam’s Endeit Capital backs Stockholm-based Eir Insurance in €20M round: Know more 

Amsterdam’s Endeit Capital backs Stockholm-based Eir Insurance in €20M round: Know more 

by TheAdviserMagazine
October 8, 2025
0

Stockholm-based Eir Insurance,  a fully licensed B2B2X white-label insurance company, has secured €20M in a growth funding round led by...

edit post
Attracting Top Talent with Employee Benefits

Attracting Top Talent with Employee Benefits

by TheAdviserMagazine
October 8, 2025
0

The talent acquisition landscape has fundamentally shifted. Competitive salaries, once the primary battleground for securing star performers, no longer guarantee...

edit post
Trump’s DOE proposes cutting billions in grants for GM, Ford, and lots of startups

Trump’s DOE proposes cutting billions in grants for GM, Ford, and lots of startups

by TheAdviserMagazine
October 7, 2025
0

The Department of Energy is looking to cut billions more in federal funding, and many promising startups as well as...

edit post
Startup Battlefield company ÄIO invented a method to make edible fat from ag waste like sawdust

Startup Battlefield company ÄIO invented a method to make edible fat from ag waste like sawdust

by TheAdviserMagazine
October 7, 2025
0

Äio (pronounced EYE-oh) is the Estonian god of dreams. It seems a sweetly appropriate namesake for a rising startup, called ÄIO, from that tiny Baltic country that has developed a process to turn agricultural...

Next Post
edit post
Eight dead in heavy overnight missile barrage

Eight dead in heavy overnight missile barrage

edit post
Can the IRS Levy a Joint Bank Account?

Can the IRS Levy a Joint Bank Account?

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
Tips to Apply for Mental Health SSDI Without Therapy

Tips to Apply for Mental Health SSDI Without Therapy

September 19, 2025
edit post
Raymond James sues to retrieve dead advisor’s laptop

Raymond James sues to retrieve dead advisor’s laptop

September 11, 2025
edit post
Who’s going to ‘eat’ tariffs? Not US shoppers

Who’s going to ‘eat’ tariffs? Not US shoppers

0
edit post
Affirm, Klarna stocks surge on new collaboration with Google (KLAR:NYSE)

Affirm, Klarna stocks surge on new collaboration with Google (KLAR:NYSE)

0
edit post
China’s Golden Week’ travel boom masks a bruising price war

China’s Golden Week’ travel boom masks a bruising price war

0
edit post
Why Citi believes blockchain is ‘here to stay’ on Wall Street

Why Citi believes blockchain is ‘here to stay’ on Wall Street

0
edit post
China Purchased B From The US In Semiconductor Chips

China Purchased $38B From The US In Semiconductor Chips

0
edit post
Bitcoin and Ether ETFs Extend Inflow Streak to 8 Days

Bitcoin and Ether ETFs Extend Inflow Streak to 8 Days

0
edit post
Affirm, Klarna stocks surge on new collaboration with Google (KLAR:NYSE)

Affirm, Klarna stocks surge on new collaboration with Google (KLAR:NYSE)

October 9, 2025
edit post
Why Citi believes blockchain is ‘here to stay’ on Wall Street

Why Citi believes blockchain is ‘here to stay’ on Wall Street

October 9, 2025
edit post
Bitcoin and Ether ETFs Extend Inflow Streak to 8 Days

Bitcoin and Ether ETFs Extend Inflow Streak to 8 Days

October 9, 2025
edit post
Gaza pact “mighty turning point” for Israeli real estate

Gaza pact “mighty turning point” for Israeli real estate

October 9, 2025
edit post
Who’s going to ‘eat’ tariffs? Not US shoppers

Who’s going to ‘eat’ tariffs? Not US shoppers

October 9, 2025
edit post
The Crash Bros are Wrong (Again!)

The Crash Bros are Wrong (Again!)

October 9, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Affirm, Klarna stocks surge on new collaboration with Google (KLAR:NYSE)
  • Why Citi believes blockchain is ‘here to stay’ on Wall Street
  • Bitcoin and Ether ETFs Extend Inflow Streak to 8 Days
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.